EB
Highly rated in
24
conditions

Dr. Emmanouil S. Brilakis

Minneapolis Heart Institute - Minneapolis
Minneapolis, MN
Highly rated in
24
conditions
Specialties:Cardiology | Interventional Cardiology
Experience:28 Years
Clinical Trials:Currently Recruiting for 4 Trials
Accepts:New PatientsMedicare
Highly rated in
24
conditions
About|Expertise|Insurance|Location|Research
Areas of Expertise

Many doctors have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions a doctor treats and their level of experience.

Check Dr. Emmanouil S. Brilakis' experience treating your condition:
About Dr. Emmanouil S. Brilakis

Emmanouil Brilakis is a Cardiologist and an Interventional Cardiologist in Minneapolis, Minnesota. Brilakis has been practicing medicine for over 28 years and is highly rated in 24 conditions, according to our data. His top areas of expertise are Coronary Heart Disease, Atherosclerosis, Peripheral Artery Disease, Percutaneous Coronary Intervention (PCI), and Atherectomy. He is licensed to treat patients in Texas and Minnesota. Brilakis is currently accepting new patients.

His clinical research consists of co-authoring 751 peer reviewed articles and participating in 22 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Emmanouil S. Brilakis it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Emmanouil S. Brilakis accepts the following insurance:

  •  Medica
  •  HealthPartners
Call to see if your plan is accepted.
Locations
800 E 28th St, Abbott Northwestern Hospital, Minneapolis, MN 55407
Other Locations
Plymouth, MN 55446
Background & Education
Graduate Institution
Other, 1995
Specialties
Cardiology
Interventional Cardiology
Licenses
Internal Medicine in TX
Hospital Affiliations
Abbott Northwestern Hospital
Cambridge Medical Center
Ridgeview Medical Center
United Hospital
Languages Spoken
English
French
Greek
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

22 Clinical Trials
Radial vs. State-Of-The-Art Femoral Access for Bleeding and Access SIte Complication Reduction in Cardiac Catheterization (REBIRTH)
Enrollment Status: Recruiting
Publish Date: June 28, 2022
Intervention Type: Procedure
Study Phase: Not Applicable
A Study to EXhibit Percutaneous Coronary Artery Dilatation With Non-Slip Element Balloon (EXPANSE-PTCA)
Enrollment Status: Recruiting
Publish Date: June 09, 2022
Intervention Type: Device
Study Phase: Not Applicable
Multicenter Registry of Chronic Total Occlusion Interventions
Enrollment Status: Recruiting
Publish Date: March 10, 2022
Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography
Enrollment Status: Recruiting
Publish Date: October 25, 2021
Intervention Type: Drug
Study Drugs: IodixanolIohexol
Study Phase: Phase 4
Chronic Total Occlusion Percutaneous Coronary Intervention CTO-PCI Study
Enrollment Status: Completed
Publish Date: September 28, 2022
Intervention Type: Procedure, Device
Study Phase: Not Applicable
A Single-Arm Study to Assess the Safety and Efficacy of the SoundBite™ Crossing System With ACTIVE Wire in Coronary Chronic Total Occlusions (the ACTIVE Trial).
Enrollment Status: Active, not recruiting
Publish Date: September 16, 2022
Intervention Type: Device
Study Phase: Not Applicable
Impact of Chronic Total Occlusion Percutaneous Coronary Intervention on Regular Physical Activity
Enrollment Status: Not yet recruiting
Publish Date: July 05, 2022
Intervention Type: Procedure
DEFINE PCI: Physiologic Assessment of Coronary Stenosis Following PCI
Enrollment Status: Completed
Publish Date: May 10, 2022
Intervention Type: Diagnostic Test
Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (FAME) 3 Trial A Comparison of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery in Patients With Multivessel Coronary Artery Disease
Enrollment Status: Active, not recruiting
Publish Date: January 20, 2022
Intervention Type: Procedure, Device
Study Phase: Not Applicable
Effect of Alirocumab on Saphenous Vein Graft Atherosclerosis: The Alirocumab for Stopping Atherosclerosis Progression in Saphenous Vein Grafts (ASAP-SVG) Pilot Trial
Enrollment Status: Terminated
Publish Date: September 16, 2021
Intervention Type: Drug
Study Phase: Phase 4
Prasugrel for Prevention of Early Saphenous Vein Graft Thrombosis
Enrollment Status: Completed
Publish Date: October 30, 2019
Intervention Type: Drug
Study Phase: Phase 3
Risk of Radiation-induced Cataracts Among Interventional Cardiology Staff- CATaracts Attributed to Radiation in the CaTh Lab: The IC-CATARACT Study
Enrollment Status: Withdrawn
Publish Date: January 18, 2019
Intervention Type: Other
Association of Lipid Core Plaque With Subsequent Clinical Outcomes: a Collaborative Near-infrared Spectroscopy Study
Enrollment Status: Withdrawn
Publish Date: January 18, 2019
REduction of Contrast Via DyeVert Used in CTO Procedures (REDUCe)
Enrollment Status: Terminated
Publish Date: May 17, 2018
Intervention Type: Device
Effect of Extended-Release Niacin on Saphenous Vein Graft Atherosclerosis: The Atherosclerosis Lesion Progression Intervention Using Niacin Extended Release in Saphenous Vein Grafts (ALPINE-SVG) Pilot Trial
Enrollment Status: Completed
Publish Date: August 17, 2017
Intervention Type: Drug
Study Phase: Phase 2
FEAT: Functional Change in Endothelium After Cardiac cAtheterization, With and Without Music Therapy
Enrollment Status: Completed
Publish Date: October 29, 2013
Intervention Type: Other
Study Phase: Phase 4
A Randomized Comparison of RADIAL Versus Femoral Access for Coronary Artery Bypass Graft Angiography and Intervention (RADIAL-CABG) Trial
Enrollment Status: Completed
Publish Date: October 29, 2013
Intervention Type: Procedure
Study Phase: Phase 3
AngiographiC Evaluation of the Everolimus-Eluting Stent in Chronic Total Occlusions - the ACE-CTO Study
Enrollment Status: Completed
Publish Date: October 29, 2013
Intervention Type: Device
Study Phase: Phase 4
Prospective Evaluation of the Xience V Everolimus-Eluting Stent In Saphenous Vein Graft Atherosclerosis: The Stenting Of Saphenous Vein Grafts Xience V Angiographic Study (SOS-Xience V)
Enrollment Status: Completed
Publish Date: October 26, 2012
Intervention Type: Device
Study Phase: Phase 4
A Retrospective Analysis Determining the Impact of Coronary Anatomy on Angina Relief in Patients Undergoing Coronary
Enrollment Status: Completed
Publish Date: August 15, 2012
The SOS (Stenting Of Saphenous Vein Grafts) Randomized-controlled Trial of a Paclitaxel-eluting Stent vs. a Bare Metal Stent in Saphenous Vein Graft Lesions
Enrollment Status: Completed
Publish Date: April 26, 2012
Intervention Type: Device
Study Phase: Phase 3
Use of Optical Coherence Tomography to Determine the Optimal Management of Patients With Drug-eluting Stents Who Need Non-cardiac Surgery
Enrollment Status: Terminated
Publish Date: December 28, 2011
Intervention Type: Device
Study Phase: Phase 4
View 18 Less Clinical Trials -
751 Total Publications
Development and validation of a scoring system for predicting clinical coronary artery perforation during percutaneous coronary intervention of chronic total occlusions: the PROGRESS-CTO perforation score.
Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
Published: October 25, 2022
Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
PS
Dr. Paul Sorajja
Interventional Cardiology | Cardiology
Highly rated in
26
conditions
Interventional Cardiology
Cardiology

Allina Health

Minneapolis Heart Institute - Minneapolis

800 E 28th St, 
Minneapolis, MN 

Paul Sorajja is an Interventional Cardiologist and a Cardiologist in Minneapolis, Minnesota. Sorajja has been practicing medicine for over 26 years and is highly rated in 26 conditions, according to our data. His top areas of expertise are Aortic Valve Stenosis, Mitral Valve Regurgitation, Mitral Stenosis, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR). He is licensed to treat patients in Minnesota. Sorajja is currently accepting new patients.

DY
Dr. Demetris Yannopoulos
Interventional Cardiology | Cardiology
Highly rated in
16
conditions
Interventional Cardiology
Cardiology

M Health Fairview

M Health Fairview University Of Minnesota Medical Center - East Bank Hospital

500 Se Harvard St, 
Minneapolis, MN 
 1.9 mi

Demetris Yannopoulos is an Interventional Cardiologist and a Cardiologist in Minneapolis, Minnesota. Yannopoulos has been practicing medicine for over 24 years and is highly rated in 16 conditions, according to our data. His top areas of expertise are Ventricular Fibrillation, Cardiac Arrest, Paroxysmal Ventricular Fibrillation, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR). He is licensed to treat patients in Minnesota. Yannopoulos is currently accepting new patients.

JT
Dr. Jay H. Traverse
Cardiology | Interventional Cardiology
Highly rated in
17
conditions
Cardiology
Interventional Cardiology

Allina Health

Minneapolis Heart Institute - Minneapolis

800 E 28th St, 
Minneapolis, MN 

Jay Traverse is a Cardiologist and an Interventional Cardiologist in Minneapolis, Minnesota. Traverse has been practicing medicine for over 34 years and is highly rated in 17 conditions, according to our data. His top areas of expertise are Heart Attack, Angina, Coronary Heart Disease, Bone Marrow Aspiration, and Percutaneous Coronary Intervention (PCI). He is licensed to treat patients in Minnesota. Traverse is currently accepting new patients.